ADVERTISEMENT

Clinical Summary

COVID-19: patients with gynaecologic cancer have higher risk for adverse outcomes

Deepa Koli   |   30 September 2022

Takeaway

  • Patients with gynaecologic cancer and COVID-19 are at higher risk for hospitalisation, delay of cancer treatment, and death. Active malignancy is associated with a 5-fold higher risk for 30-day mortality after COVID-19 diagnosis.

Why this matters

  • The authors said, “These results create a sense of urgency to further explore...

          

November Challenge

Ends in 9h
left
right

Topic Challenges

left
right